ArticleCNS neuroscience & therapeutics2026
Acupuncture Modulates Neurotransmitter-Related Molecules in the Amygdala to Ameliorate Generalized Anxiety Disorder.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundNeurotransmitter imbalance is a key mechanism contributing to the heightened negative emotions and anhedonia associated with anxiety disorders. However, whether acupuncture exerts its anxiolytic effects by modulating neurotransmitter imbalance remains unclear.
methodsSeventy generalized anxiety disorder (GAD) patients were recruited and randomly assigned to acupuncture or wait-list groups. The Hamilton Anxiety Rating Scale (HAMA) and fMRI scans were used before and after treatment to assess anxiety levels and brain activity. In parallel, male Sprague-Dawley rats were divided into four groups: control, chronic unpredictable stress model (CUS), electroacupuncture (EA), and sham acupuncture (SA). The EA group received stimulation at specific acupuncture points over 21 days, while the CUS group experienced chronic unpredictable stress to induce anxiety. Behavioral assessments and molecular analyses, including qRT-PCR, Western blotting, and immunofluorescence, measured neurotransmitter levels.
resultsClinically, the acupuncture group exhibited a significant reduction in HAMA scores compared to baseline (p < 0.001), unlike the wait-list group. fMRI results indicated decreased ReHo in brain regions such as the amygdala, hippocampus, anterior and posterior cingulate cortices, putamen, and precuneus following acupuncture (GRF-corrected p-cluster < 0.05). These reductions showed overlap in the anterior and posterior cingulate cortices between both groups. A positive correlation was found between reduced ReHo in the amygdala and the decrease in HAMA scores (rs = 0.390, p = 0.023), while a negative correlation was observed between reduced ReHo in the hippocampus and illness duration (rs = -0.385, p = 0.025). In the animal model, EA improved body weight and reduced anxiety-like behaviors (p < 0.05). EA increased IGF-1 expression in the mPFC and amygdala, and decreased NR2B, GluR2 in the amygdala (p < 0.05).
conclusionAcupuncture shows potential in treating anxiety disorders by modulating IGF-1 and NR2B expression, thus restoring neurotransmitter balance in the mPFC-amygdala pathway. In both animal models and clinical settings, acupuncture effectively reduced anxiety symptoms and induced positive changes in brain regions such as the amygdala and hippocampus. These findings provide preliminary evidence for using acupuncture in the treatment of GAD. CLINICAL TRIAL NUMBER: MR-46-23-043956.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.